Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus sitagliptin for endothelial function in type 2 diabetes
2011-000893-68Phase 4Terminated
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide arm with Sitagliptin arm (2 arms). Primary endpoint: Change in endothelial function. Started Jul 2012; status: terminated.
02
Drugs
liraglutidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-000893-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000893-68.